CORRECTED-UPDATE 1-FDA approves cheaper Botox rival to treat frown lines (Feb.1)
February 04, 2019 at 06:36 AM EST
An injection to treat forehead wrinkles is set to rival Allergan's Botox after U.S. regulators approved Evolus Inc's cheaper treatment on Friday, sending its shares up about 5 percent after the bell.
